EquityZen Growth Technology Fund LLC - Series 2216
Raised
$179K
Investors
13
Min Invest
$10,038
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2216 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors LLC and Phil Haslett on 2025-12-05. The fund raised $179K from 13 investors under Regulation D Rule 506(b) and 3(c)(1) exemptions, with a $10K minimum investment. It is part of EquityZen's platform of 1,889 pre-IPO investment vehicles.
This pre-IPO fund operates under the standard 506(b)/3(c)(1) exemption structure typical of private securities platforms, with a $10K minimum investment representing the retail-accessible tier. The raise size and investor count are consistent with single-company SPV structures targeting early-stage or late-stage private company exposure.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
